Prevention of stroke and systemic embolism using the oral direct Factor Xa inhibitor rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: the ROCKET AF trial - Patel, MR; Mahaffey, KW; Garg, J (N Engl J Med, 2011)
et al.